Treatment of hepatitis C virus genotype 2 and 3 with pegylated interferon plus ribavirin - Reply

被引：15
|
作者：
Zeuzem, S [1 ]
机构：
[1] Saarland Univ Hosp, D-66421 Homburg, Germany
来源：
JOURNAL OF HEPATOLOGY | 2005年 / 42卷 / 02期
关键词：
D O I：
10.1016/j.jhep.2004.11.012
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：276 / 277
页数：2
相关论文
共 50 条
  • [31] Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: Some issues - Reply
    Kamal, Sanaa
    Schardell, Michelle
    El Kamary, Samer
    Hashem, Mohamed
    Mansour, Hoda
    Ibrahim, Amany Sayed
    [J]. HEPATOLOGY, 2008, 47 (05) : 1793 - 1794
  • [32] Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C
    PN Rao
    Abraham Koshy
    Jacob Philip
    Narayanan Premaletha
    Joy Varghese
    Krishnasamy Narayanasamy
    Samir Mohindra
    Nitin Vikas Pai
    Manoj Kumar Agarwal
    Ashokna Konar
    Hasmukh B Vora
    [J]. World Journal of Hepatology, 2014, (07) : 520 - 526
  • [33] Pegylated interferon α2a plus ribavirin versus pegylated interferon α2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients
    Berenguer, J.
    Gonzalez-Garcia, J.
    Lopez-Aldeguer, J.
    Von-Wichmann, M. A.
    Quereda, C.
    Hernando, A.
    Sanz, J.
    Tural, C.
    Ortega, E.
    Mallolas, J.
    Santos, I.
    Miralles, P.
    Montes, M. L.
    Bellon, J. M.
    Esteban, H.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (06) : 1256 - 1263
  • [34] Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C
    Rao, P. N.
    Koshy, Abraham
    Philip, Jacob
    Premaletha, Narayanan
    Varghese, Joy
    Narayanasamy, Krishnasamy
    Mohindra, Samir
    Pai, Nitin Vikas
    Agarwal, Manoj Kumar
    Konar, Ashoknanda
    Vora, Hasmukh B.
    [J]. WORLD JOURNAL OF HEPATOLOGY, 2014, 6 (07) : 520 - 526
  • [35] Low-Dose Pegylated Interferon α-2b Plus Ribavirin for Elderly and/or Cirrhotic Patients with Genotype 2 Hepatitis C Virus
    Tamai, Hideyuki
    Shingaki, Naoki
    Mori, Yoshiyuki
    Moribata, Kosaku
    Kawashima, Akira
    Maeda, Yoshimasa
    Niwa, Toru
    Deguchi, Hisanobu
    Inoue, Izumi
    Maekita, Takao
    Iguchi, Mikitaka
    Kato, Jun
    Ichinose, Masao
    [J]. GUT AND LIVER, 2016, 10 (04) : 617 - 623
  • [36] Effects of Host and virus related factors on Interferon-α plus ribavirin and Pegylated-interferon plus ribavirin treatment outcomes in Chronic Hepatitis C patients
    Akram, Madiha
    Idrees, Muhammad
    Zafar, Shamail
    Hussain, Abrar
    Butt, Sadia
    Afzal, Samia
    Rehman, Irshad-ur
    Liaqat, Ali
    Saleem, Sana
    Ali, Muhammad
    Butt, Azeem
    [J]. VIROLOGY JOURNAL, 2011, 8
  • [37] Pegylated interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C genotype
    Hasan, F
    Asker, H
    Al-Khaldi, J
    Siddique, I
    Owaid, SF
    Al-Ajmi, M
    Al-Nakib, B
    [J]. HEPATOLOGY, 2003, 38 (04) : 629A - 629A
  • [38] Pegylated Interferon and Ribavirin for the Treatment of Chronic Hepatitis C
    Kemp, William
    Roberts, Stuart
    [J]. CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2011, 3 : 137 - 150
  • [39] PEGYLATED INTERFERON AND RIBAVIRIN TREATMENT FOR CHILDREN WITH HEPATITIS C
    Adiv, O. Eshach
    Zion, N.
    Shaoul, R.
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2010, 50 : E161 - E161
  • [40] Favorable factors for re-treatment with pegylated interferon a2a plus ribavirin in patients with high viral loads of genotype 1 hepatitis C virus
    Tamori, Akihiro
    Kioka, Kiyohide
    Kurai, Osamu
    Sakaguchi, Hiroki
    Enomoto, Masaru
    Fujii, Hideki
    Kobayashi, Sawako
    Iwai, Shuji
    Morikawa, Hiroyasu
    Yamaguchi, Seiko
    Kawasaki, Yasuko
    Oka, Hiroko
    Tanaka, Yasuhito
    Kawada, Norifumi
    [J]. HEPATOLOGY RESEARCH, 2011, 41 (12) : 1169 - 1177
12345